Prot # BCX1812-303: A Phase 3, Open-Label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects with Confirmed or Suspected Influenza Infection

  • Ison, Michael G (PD/PI)

Project: Research project

Project Details

Effective start/end date9/28/099/27/12


  • Quintiles, Inc. (BCX1812-303 // BCX1812-303)
  • Biocryst Pharmaceuticals, Inc. (BCX1812-303 // BCX1812-303)